Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation

scientific article published in March 2012

Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/0284186X.2011.624118
P698PubMed publication ID22497435

P50authorRickard LjungQ37836694
Gunnar SteineckQ39509247
Mats TalbäckQ57303250
P2093author name stringBengt Haglund
Junmei Miao Jonasson
Soffia Gudbjörnsdòttir
P433issue3
P921main subjectinsulin glargineQ417317
P304page(s)400-402
P577publication date2012-03-01
P1433published inActa OncologicaQ326164
P1476titleInsulin glargine use and short-term incidence of breast cancer - a four-year population-based observation
P478volume51

Reverse relations

cites work (P2860)
Q100633876A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
Q37278227Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin
Q37331188Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.
Q90437639Does long-term use of antidiabetic drugs changes cancer risk?
Q35044151Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.
Q35817986Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality
Q90919337Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study
Q27026813The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms
Q26852910The links between insulin resistance, diabetes, and cancer
Q35038355Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Search more.